Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 12—December 2020
Dispatch

Hantavirus Cardiopulmonary Syndrome in Canada

Bryce M. Warner, Sebastian Dowhanik1, Jonathan Audet, Allen Grolla, Daryl Dick2, James E. Strong, Darwyn Kobasa, L. Robbin Lindsay, Gary Kobinger3, Heinz Feldmann4, Harvey Artsob2, Michael A. Drebot, and David SafronetzComments to Author 
Author affiliations: Public Health Agency of Canada, Winnipeg, Manitoba, Canada (B.M. Warner, S. Dowhanik, J. Audet, A. Grolla, D. Dick, J.E. Strong, D. Kobasa, L.R. Lindsay, G. Kobinger, H. Feldmann, H. Artsob, M.A. Drebot, D. Safronetz); University of Manitoba, Winnipeg (B.M. Warner, J.E. Strong, D. Kobasa, L.R. Lindsay, G. Kobinger, H. Feldmann, M.A. Drebot, D. Safronetz)

Main Article

Table

Comparison of outcomes for confirmed cases of hantavirus cardiopulmonary syndrome in male and female patients, Canada

Sex No. fatal cases No. nonfatal cases Relative risk (95% CI) p value
(χ2 test)
M 19 75 1.726 (0.9733−3.060) 0.0651
F
 15
 28
Total 34 103

Main Article

1Current affiliation: McMaster University, Hamilton, Ontario, Canada.

2Retired.

3Current affiliation: Université Laval, Quebec City, Quebec, Canada.

4Current affiliation: National Institutes of Health, Hamilton, Montana, USA.

Page created: October 08, 2020
Page updated: November 19, 2020
Page reviewed: November 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external